Milan Čižman

Dr. Milan Čižman

Department of Infectious Diseases, University Medical Centre Ljubljana, Japljeva 2, 1525 Ljubljana, Slovenia

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2003 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
MČMilan Čižman
Milan Čižman

1 April 2001 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
MČMilan Čižman
Milan Čižman
MPMarko Pokorn
Marko Pokorn
KSKatja Seme
Katja Seme
AOAndreja Oražem
Andreja Oražem
MPMetka Paragi
Metka Paragi
The correlation between increased macrolide consumption and the resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to macrolides in Slovenia from 1994 to 1999 was evaluated. The outpatient consumption of macrolides increased from 1.89 to 3.84 defined daily doses (DDD)/1000 inhabitants/day during the observation period. This increase in macrolide consumption was paralleled by a steady increase in macrolide resistance in S. pyogenes (from 0 to 7.4%, r = 0.90, P = 0.014) and upper respiratory S. pneumoniae isolates (from 0 to 9%, r = 0.82, P = 0.044). In other pathogens studied, no significant increase was detected.

Verified
Open access
MČMilan Čižman
Milan Čižman
TSTina Plankar Srovin
Tina Plankar Srovin

1 April 2001 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
MČMilan Čižman
Milan Čižman
AOAndreja Oražem
Andreja Oražem
VKVeronika Križan-Hergouth
Veronika Križan-Hergouth
JKJana Kolman
Jana Kolman
Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli. Journal of Urology 153, 117-20.

1 September 2004 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
MČMilan Čižman
Milan Čižman
BBBojana Beovic
Bojana Beovic
VKVladimir Krcmery
Vladimir Krcmery
BBBruno Barsic
Bruno Barsic
ETEda Tamm
Eda Tamm
PDPeter Dvorák
Peter Dvorák

1 May 2005 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
MČMilan Čižman
Milan Čižman
TST. Srovin
T. Srovin
MPMarko Pokorn
Marko Pokorn
SPS. Čad Pečar
S. Čad Pečar
SBSaba Battelino
Saba Battelino
Objectives: Compared with European countries, the use of antibiotics in Slovenia is moderate. In the period 1999–2002 an 18.67% decrease in outpatient antibiotic consumption was noted. The aim of the present study was to analyse this decrease and its consequences. Methods: The data on outpatient antibiotic consumption were obtained from the Institute of Public Health and Health Insurance Institute of Slovenia and expressed in defined daily doses (DDD)/1000 inhabitant-days. The number of media publications on ‘antibiotic drugs’ and ‘bacterial resistance’ during the study period was obtained. In 2000, the prescription of co-amoxiclav and fluoroquinolones was restricted because of a constant increase in the consumption of these drugs. The data on incidence of acute mastoiditis and penicillin resistance among invasive pneumococci were obtained. Results: The total outpatient consumption of antibacterials increased from 15.21 DDD/1000 inhabitant-days in 1996 to 20.08 in 1999, and decreased to 16.97 in 2003. The consumption of restricted antibiotics decreased from 7.29 in 1999 to 5.25 DDD/1000 inhabitant-days in 2003. There was a positive correlation between antibiotic consumption and the number of newspaper articles (r=0.92), and a negative correlation between the number of diagnostic tests and antibiotic consumption (r=−0.73 for the C-reactive protein test and −0.68 for the streptococcal antigen detection test). Reduced antibiotic consumption was paralleled by a decrease in penicillin resistance among invasive pneumococci. No increase in mastoiditis cases was observed in spite of reduced antibiotic consumption. Conclusion: Restriction of antibiotic prescription proved to be effective in reducing outpatient antibiotic consumption. The effect was prolonged and affected restricted antibiotics as well as non-restricted drugs.